Research sheds light on post-sepsis immune suppression mechanism

Severe sepsis from bacterial or viral infections can be life-threatening and even people recovering from severe sepsis may experience long-lasting effects on the immune system, making them more susceptible to recurrent infections.

DeepMind Nobel Prize winner says AI will have “electricity” type of impact – Pharmaceutical Technology

Demis Hassabis leading a keynote interview at the FT Live Global Pharma and Biotech Summit in London. Credit: Jenna Philpott / GlobalData. The role of

November 7, 2024

Amgen reports dual Phase 3 wins in atopic dermatitis and myasthenia gravis

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 25, 2024

INTEGRA Biosciences’ reagent dispenser now supports SiLA-2 integration

INTEGRA Biosciences’ WELLJET reagent dispenser now supports API commands based on the SiLA-2 standardized communication protocol for lab automation. This new functionality will make it even

January 31, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.